Perfusion guidewire in combination with a distal filter

Information

  • Patent Grant
  • 7785344
  • Patent Number
    7,785,344
  • Date Filed
    Wednesday, May 3, 2006
    18 years ago
  • Date Issued
    Tuesday, August 31, 2010
    14 years ago
Abstract
The present invention relates generally to perfusion catheters and distal protection devices. According to an embodiment, the present invention includes a distal protection filter comprising an elongate shaft having a proximal end and a distal end, a distal protection device disposed at the distal end, a coupling member that couples the elongate shaft to the distal protection device, and a first space between the coupling member and the elongate shaft. A method of filtering debris from a blood vessel is also disclosed.
Description
FIELD OF THE INVENTION

The present invention generally relates to perfusion guidewires. More particularly, the present invention relates to perfusion guidewires used in combination with a distal protection device.


BACKGROUND OF THE INVENTION

Heart disease is a major problem in the United States and throughout the world. Conditions such as atherosclerosis result in blood vessels becoming blocked or narrowed. This blockage can result in lack of oxygenation to the heart, which has significant consequences since the heart muscle must be well oxygenated to maintain its blood pumping action.


Occluded, stenotic, or narrowed blood vessels may be treated with a number of relatively non-invasive medical procedures including percutaneous transluminal angioplasty (PTA), percutaneous transluminal coronary angioplasty (PTCA), and atherectomy. Angioplasty techniques typically involve the use of a balloon catheter. The balloon catheter is advanced over a guidewire such that the balloon is positioned adjacent a stenotic lesion. The balloon is then inflated and the restriction of the vessel is opened. During an atherectomy procedure, the stenotic lesion may be mechanically cut away from the blood vessel wall using an atherectomy catheter.


During angioplasty and atherectomy procedures, stenotic debris can be separated from the wall of the blood vessel. If this debris enters the circulatory system, it could block other vascular regions including the neural and pulmonary vasculature, both of which are highly undesirable. An occlusion in the neural vasculature may cause a stroke, and an occlusion in the lungs may interfere with the oxygenation of the blood. During angioplasty procedures, stenotic debris may also break loose due to manipulation of the blood vessel. Because of this debris, a number of devices termed distal protection devices have been developed to filter out this debris.


SUMMARY OF THE INVENTION

The present invention pertains to a refinement to distal protection devices. More particularly, an embodiment of the present invention comprises a filter coupled to an elongate shaft by a coupling member. The coupling member is designed to limit coagulation of blood near the junction of the guidewire and the distal protection device.


An embodiment of the invention comprises an elongate shaft having a filter disposed proximate a distal end thereof. The filter may include devices generally adapted to prevent debris from traveling away from a treatment site during or after an intravascular procedure. The filter has at least one opening that may allow the passage of blood and substantially prevent debris (e.g., debris produced by an angioplasty or atherectomy procedure) from flowing therethrough.


The filter may be coupled to the elongate shaft by a coupling member. The coupling member may comprise a coil that is disposed about the elongate shaft. At least a portion of the coil may be coupled to the elongate shaft. An alternate coupling member may comprise a porous tube having a proximal end and a distal end.


The coupling member may be coupled to the elongate shaft and provide spaces and/or opening that permits blood flow but substantially prevent debris from passing therethrough. According to this embodiment, allowing blood through the coupling member will minimize coagulation and clotting of blood proximate the coupling member. To further limit coagulation and clotting, the coupling member, the distal protection device, and the shaft may be treated with an anti-coagulation agent.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a partial cross sectional view of a distal protection filter;



FIG. 2 is a cross sectional view of the coupling member of the filter shown in FIG. 1;



FIG. 3 is a cross sectional view of the coupling member attached to the elongate shaft in at an alternative manner;



FIG. 4 is a cross sectional view of the coupling member attached to the elongate shaft in at a second alternative manner; and



FIG. 5 is a partial cross sectional view of a distal protection filter having an alternate coupling member.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The following description should be read with reference to the drawings wherein like reference numerals indicate like elements throughout the several views. The detailed description and drawings illustrate example embodiments of the claimed invention.



FIG. 1 is a partial cross sectional view of a distal protection filter 10. Distal protection filter 10 includes a filter frame 12 coupled to an elongate shaft 14 by a perfusion coupling member 16. Filter 10 may be used to filter debris from a blood vessel in conjunction with a medical procedure that produces embolic debris (e.g., angioplasty, atherectomy, etc.). Coupling member 16 may serve to minimize thrombus formation near the junction of filter frame 12 and shaft 14 by allowing fluid to perfuse therethrough.


Filter frame 12 may be disposed proximate a distal end 18 of shaft 14. A filter material 20 having at least one opening 22 may be coupled to frame 12. Filter material 20 may be constructed of a polyurethane sheet, and openings 22 may be formed in the polyurethane sheet by known laser techniques. Holes or openings are sized to allow blood flow therethrough but restrict flow of debris or emboli floating in the body lumen or cavity.


Filter 10 may be generally cone-shaped, and have a proximal mouth portion 24 a distal end 26. Distal end 26 can be narrow and/or generally ā€œVā€-shaped. Filter 10 operates between a closed collapsed profile and an open radially-expanded deployed profile for collecting debris in a body lumen. Frame includes a plurality of longitudinally-extending struts 28 extending from mouth portion 24. Struts 28 may be coupled to elongate shaft 14 by a strut coupling 30.


Elongate shaft 14 may be a guidewire that is generally metallic. For example, shaft 14 may be comprised of stainless steel, super elastic alloys (e.g., nitinol), or other suitable materials. Alternatively, shaft 14 may be comprised of a polymer or a metal-polymer composite. A distal spring tip 32 may be disposed at distal end 18. It can be appreciated that elongate shaft 14 could include an intravascular catheter, a tube having a lumen, an intravascular device, etc.


Coupling member 16 may comprise a coil that is disposed about elongate shaft 14. It should be noted that the coil of coupling member 16 is depicted in FIG. 1 (as well as analogous coils in FIG. 2-4) in cross-section and, thus, appears as a plurality of circles. Filter 10 may be coupled to coupling member by any one of a number of methods. For example, filter 10 may be heat bonded to the coil. Alternatively, filter 10 may be coupled to coupling member by adhesive, solder, crimping, or other suitable methods.


At least a portion of the coil (e.g., at least a portion of one winding) is attached to elongate shaft 14. For example, the coil may be attached to elongate shaft 14 at a position that is located distally of distal end 26 of filter frame 12 (FIG. 2). Alternatively, the coil may be coupled to elongate shaft 14 at a position that is near distal end 26 (FIG. 3). According to this embodiment, the coil may be further coupled to elongate shaft 14 at a location distal of distal end 26. In another alternate embodiment, the coil may be coupled to elongate shaft 14 at multiple locations along the length of elongate shaft 14 (FIG. 4). A more detailed description of the aforementioned embodiments may be found below.



FIG. 2 is a cross sectional view of coupling member 16 wherein coupling member 16 is coupled to elongate shaft 14 at a location that is distal of distal end 26 of filter frame 12. According to this embodiment, distal end 26 of filter frame 12 may be a first distance 34 away from elongate shaft 14. First distance 34 and the width of openings 22 within filter material 20 are approximately equal. First distance 34 defines a space between coupling member 16 and elongate shaft 14 to permit blood flow therethrough.


The coil of coupling member 16 has a relatively open pitch that defines a second distance 36 between individual winding of the coil. According to this embodiment, blood can flow through a space between the windings of the coil in a generally circular direction that follows the coil. Second distance 38 may be approximately equal to the width of openings 22. In an exemplary embodiment, first distance 34, second distance 36, and the width of openings 22 are all approximately equal.


It can be appreciated that blood will pass between coupling member 16 and shaft 14 through spaces therebetween and/or spaces between the individual winding of the coil. Permitting blood flow through coupling member 16 will minimize coagulation and clotting of blood proximate coupling member 16. To further minimize coagulation and clotting, coupling member 16, filter material 20, elongate shaft 14, etc. may be treated with an anti-coagulation agent. An anti-coagulation agent may include substances including, but not limited to, silicon, anti-coagulants, warfarin, nicoumalone, phenindione, heparin, low-molecular-weight heparins, anti-thrombin agents, dermatan sulfate, hirugen, argatroban, peptide chloromethyl ketone inhibitors, ancrod, anti-platelet agents, aspirin, epoprostenol, prostacyclin, ticlopidine, antibodies against the GPIIb/IIIa (glycoprotein IIb/IIIb) receptor, TXA2 (thromboxane A2) synthesis inhibitors, TXA2 receptor antagonists, anti-fibrinolytic agents, tranexamic acid, aprotinin, ethamsylate, and combinations thereof. These anti-coagulation agents may be disposed at any one of the above listed locations by multiple methods including dipping any of the objects into the anti-coagulation agents.



FIG. 3 is a cross sectional view of coupling member 16 attached to elongate shaft 14 at both a location distal of distal end 26 and a location proximal of distal end 26. This additional attachment point between coupling member 16 and shaft 14 may more securely couple filter frame 12 to shaft 14. In addition, blood flow will be permitted along the windings of the coil and through the space between the coil and shaft 14.



FIG. 4 is a cross sectional view of coupling member 16 attached to elongate shaft 14 at multiple locations. According to this embodiment, the lack of spacing between frame 12 and shaft 14, will limit blood flow to being through winding of the coil. Securing coupling member 16 to shaft 14 at multiple locations may further strengthen the bond between frame 12 and shaft 14.



FIG. 5 is a partial cross sectional view of an alternate coupling member 116. Coupling member 116 may comprise a porous tube 138 having a proximal end 140 and a distal end 142 and is disposed over a portion of elongate shaft 14 a distance (analogous to first distance 34) away from shaft 14. The distance between tube 138 and shaft 14 defines a space therebetween.


Porous tube 138 may further comprise a first opening 144 near proximal end 140 and a second opening 146 near distal end 142. Filter frame 12 may be coupled to porous tube 138 between first opening 144 and second opening 146. The width of first opening 144 and second opening 146 may be approximately equal to the width of openings 22 in filter material 20. First opening 144 and second opening 146 are in fluid communication with one another through the space defined between shaft 14 and tube 138. It can be appreciated that porous tube 138 may include additional openings.


Similar to what is disclosed above, first opening 144 and second opening 146 may permit flow of blood but substantially prevent debris from flowing therethrough that might occlude a blood vessel. According to this embodiment, blood may enter first opening 146, migrate distally (i.e., toward distal end 18 of elongate shaft 14) within the space between shaft 14 and tube 138, and exit porous tube 138 through second opening 146. Allowing blood to pass through tube 138 may limit coagulation and clotting of blood proximate coupling member 316. Similar to what is disclosed above, coupling member 116 may be treated with substances including anti-coagulants, anti-thrombin agents, anti-platelet agents, anti-fibrinolytic agents, etc.


In addition, a method for filtering debris for a blood vessel in disclosed that utilizes any of the devices listed above. The method comprises the steps of providing elongate shaft 14 including filter 10 coupled thereto, positioning elongate shaft 14 within a blood vessel downstream of a medical procedure that may generate debris (e.g., angioplasty, atherectomy, etc.), collecting the debris with filter material 20, and allowing blood to flow through coupling member 16 (and/or coupling member 116). The method may also include the step of treating any of the above elements with an anti-coagulation agent.


It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.

Claims
  • 1. An embolic protection filter, comprising: a solid shaft having a proximal end and a distal end;a filter coupled to the distal end of the shaft, the filter including a filter frame having a filter material coupled thereto, the filter material having one or more openings defined therein; anda perfusion member disposed between and coupled to the shaft and the filter, the perfusion member having one or more openings therethrough which permit blood to flow from an upstream side of the filter between the shaft and the filter to a downstream side of the filter and substantially prevent debris from passing;wherein the perfusion member includes a porous tube.
  • 2. The filter of claim 1, further comprising an anti-coagulation agent disposed adjacent the perfusion member.
Parent Case Info

This application is a continuation application of U.S. patent application Ser. No. 10/140,404, filed on May 6, 2002 now U.S. Pat. No. 7,060,082.

US Referenced Citations (163)
Number Name Date Kind
3472230 Fogarty Oct 1969 A
3952747 Kimmell, Jr. Apr 1976 A
3996938 Clark, III Dec 1976 A
4046150 Schwartz et al. Sep 1977 A
4086665 Poirier May 1978 A
4425908 Simon Jan 1984 A
4590938 Segura et al. May 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4643184 Mobin-Uddin Feb 1987 A
4650466 Luther Mar 1987 A
4662885 DiPisa, Jr. May 1987 A
4706671 Weinrib Nov 1987 A
4723549 Wholey et al. Feb 1988 A
4790812 Hawkins, Jr. et al. Dec 1988 A
4790813 Kensey Dec 1988 A
4794928 Kletschka Jan 1989 A
4807626 McGirr Feb 1989 A
4842579 Shiber Jun 1989 A
4857045 Rydell Aug 1989 A
4873978 Ginsburg Oct 1989 A
4886061 Fischell et al. Dec 1989 A
4921478 Solano et al. May 1990 A
4921484 Hillstead May 1990 A
4926858 Gifford, III et al. May 1990 A
4969891 Gewertz Nov 1990 A
4998539 Delsanti Mar 1991 A
5002560 Machold et al. Mar 1991 A
5011488 Ginsburg Apr 1991 A
5049132 Shaffer et al. Sep 1991 A
5053008 Bajaj Oct 1991 A
5071407 Termin et al. Dec 1991 A
5100423 Fearnot Mar 1992 A
5102415 Guenther et al. Apr 1992 A
5133733 Rasmussen et al. Jul 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5152777 Goldberg et al. Oct 1992 A
5160342 Reger et al. Nov 1992 A
5192286 Phan et al. Mar 1993 A
5224953 Morgentaler Jul 1993 A
5324304 Rasmussen Jun 1994 A
5329942 Gunther et al. Jul 1994 A
5330484 Gunther Jul 1994 A
5354310 Garnie et al. Oct 1994 A
5370657 Irie Dec 1994 A
5376100 Lefebvre Dec 1994 A
5415630 Gory et al. May 1995 A
5419774 Willard et al. May 1995 A
5421832 Lefebvre Jun 1995 A
5423742 Theron Jun 1995 A
5449372 Schmaltz et al. Sep 1995 A
5456667 Ham et al. Oct 1995 A
5462529 Simpson et al. Oct 1995 A
5536242 Willard et al. Jul 1996 A
5549626 Miller et al. Aug 1996 A
5658296 Bates et al. Aug 1997 A
5662671 Barbut et al. Sep 1997 A
5669933 Simon et al. Sep 1997 A
5695519 Summers et al. Dec 1997 A
5720764 Naderlinger Feb 1998 A
5728066 Daneshvar Mar 1998 A
5749848 Jang et al. May 1998 A
5769816 Barbut et al. Jun 1998 A
5779716 Cano et al. Jul 1998 A
5792157 Mische et al. Aug 1998 A
5795322 Boudewijn Aug 1998 A
5800457 Gelbfish Sep 1998 A
5800525 Bachinski et al. Sep 1998 A
5807398 Shaknovich Sep 1998 A
5810874 Lefebvre Sep 1998 A
5814064 Daniel et al. Sep 1998 A
5827324 Cassell et al. Oct 1998 A
5833644 Zadno-Azizi et al. Nov 1998 A
5833650 Imran Nov 1998 A
5846260 Maahs Dec 1998 A
5848964 Samuels Dec 1998 A
5876367 Kaganov et al. Mar 1999 A
5895399 Barbut et al. Apr 1999 A
5910154 Tsugita et al. Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5925016 Chornenky et al. Jul 1999 A
5925060 Forber Jul 1999 A
5925062 Purdy Jul 1999 A
5935139 Bates Aug 1999 A
5941869 Patterson et al. Aug 1999 A
5941896 Kerr Aug 1999 A
5947995 Samuels Sep 1999 A
5954745 Gertler et al. Sep 1999 A
5980555 Barbut et al. Nov 1999 A
5989281 Barbut et al. Nov 1999 A
5993469 McKenzie et al. Nov 1999 A
5997557 Barbut et al. Dec 1999 A
6001118 Daniel et al. Dec 1999 A
6007557 Ambrisco et al. Dec 1999 A
6010522 Barbut et al. Jan 2000 A
6013085 Howard Jan 2000 A
6027520 Tsugita et al. Feb 2000 A
6042598 Tsugita et al. Mar 2000 A
6051014 Jang Apr 2000 A
6051015 Maahs Apr 2000 A
6053932 Daniel et al. Apr 2000 A
6059814 Ladd May 2000 A
6066149 Samson et al. May 2000 A
6066158 Engelson et al. May 2000 A
6068645 Tu May 2000 A
6086605 Barbut et al. Jul 2000 A
6102932 Kurz Aug 2000 A
6117154 Barbut et al. Sep 2000 A
6129739 Khosravi Oct 2000 A
6136016 Barbut et al. Oct 2000 A
6142987 Tsugita Nov 2000 A
6152946 Broome et al. Nov 2000 A
6165200 Tsugita et al. Dec 2000 A
6168579 Tsugita Jan 2001 B1
6171327 Daniel et al. Jan 2001 B1
6171328 Addis Jan 2001 B1
6179851 Barbut et al. Jan 2001 B1
6179859 Bates et al. Jan 2001 B1
6179861 Khosravi et al. Jan 2001 B1
6187025 Machek Feb 2001 B1
6203561 Ramee et al. Mar 2001 B1
6206868 Parodi Mar 2001 B1
6214026 Lepak et al. Apr 2001 B1
6221006 Dubrul et al. Apr 2001 B1
6224620 Maahs May 2001 B1
6231544 Tsugita et al. May 2001 B1
6235044 Root et al. May 2001 B1
6235045 Barbut et al. May 2001 B1
6238412 Dubrul et al. May 2001 B1
6245066 Morgan et al. Jun 2001 B1
6245087 Addis Jun 2001 B1
6245088 Lowery Jun 2001 B1
6245089 Daniel et al. Jun 2001 B1
6258115 Dubrul Jul 2001 B1
6264663 Cano Jul 2001 B1
6264672 Fisher Jul 2001 B1
6277139 Levinson et al. Jul 2001 B1
6270513 Tsugita et al. Aug 2001 B1
6277138 Levinson et al. Aug 2001 B1
6280413 Clark et al. Aug 2001 B1
6287321 Jang Sep 2001 B1
6290710 Cryer et al. Sep 2001 B1
6309399 Barbut et al. Oct 2001 B1
6319268 Ambrisco et al. Nov 2001 B1
6344049 Levinson et al. Feb 2002 B1
6605102 Mazzocchi et al. Aug 2003 B1
6726703 Broome et al. Apr 2004 B2
6918921 Brady et al. Jul 2005 B2
6969396 Krolik et al. Nov 2005 B2
6997938 Wang et al. Feb 2006 B2
7060082 Goll et al. Jun 2006 B2
7097440 Papp et al. Aug 2006 B2
20020177872 Papp et al. Nov 2002 A1
20040006361 Boyle et al. Jan 2004 A1
20040068288 Palmer et al. Apr 2004 A1
20040093010 Gesswein et al. May 2004 A1
20040167565 Beulke et al. Aug 2004 A1
20040249409 Krolik et al. Dec 2004 A1
20040260331 D'Aquanni et al. Dec 2004 A1
20050010245 Wasicek Jan 2005 A1
20050096692 Linder et al. May 2005 A1
20060100659 Dinh et al. May 2006 A1
20060149313 Arguello et al. Jul 2006 A1
20060155322 Sater et al. Jul 2006 A1
Foreign Referenced Citations (109)
Number Date Country
28 21 048 Jul 1980 DE
34 17 738 Nov 1985 DE
40 30 998 Oct 1990 DE
199 16 162 Oct 2000 DE
0 200 688 Nov 1986 EP
0 293 605 Dec 1988 EP
0 411 118 Feb 1991 EP
0 427 429 May 1991 EP
0 437 121 Jul 1991 EP
0 472 334 Feb 1992 EP
0 472 368 Feb 1992 EP
0 533 511 Mar 1993 EP
0 655 228 Nov 1994 EP
0 686 379 Jun 1995 EP
0 696 447 Feb 1996 EP
0 737 450 Oct 1996 EP
0 743 046 Nov 1996 EP
0 759 287 Feb 1997 EP
0 771 549 May 1997 EP
0 784 988 Jul 1997 EP
0 852 132 Jul 1998 EP
1 127 556 Aug 2001 EP
2 580 504 Oct 1986 FR
2 643 250 Aug 1990 FR
2 666 980 Mar 1992 FR
2 694 687 Aug 1992 FR
2 768 326 Mar 1999 FR
2 020 557 Jan 1983 GB
8-187294 Jul 1996 JP
764684 Sep 1980 SU
WO 8809683 Dec 1988 WO
WO 9203097 Mar 1992 WO
WO 9414389 Jul 1994 WO
WO 9424946 Nov 1994 WO
9601591 Jan 1996 WO
WO 9610375 Apr 1996 WO
WO 9619941 Jul 1996 WO
WO 9623441 Aug 1996 WO
WO 9633677 Oct 1996 WO
WO 9717100 May 1997 WO
WO 9727808 Aug 1997 WO
WO 9742879 Nov 1997 WO
WO 9802084 Jan 1998 WO
WO 9802112 Jan 1998 WO
WO 9823322 Jun 1998 WO
WO 9833443 Aug 1998 WO
WO 9834673 Aug 1998 WO
WO 9836786 Aug 1998 WO
WO 9838920 Sep 1998 WO
WO 9838929 Sep 1998 WO
WO 9839046 Sep 1998 WO
WO 9839053 Sep 1998 WO
WO 9846297 Oct 1998 WO
WO 9847447 Oct 1998 WO
WO 9849952 Nov 1998 WO
WO 9850103 Nov 1998 WO
WO 9851237 Nov 1998 WO
WO 9855175 Dec 1998 WO
WO 9909895 Mar 1999 WO
WO 9922673 May 1999 WO
WO 9923976 May 1999 WO
WO 9925252 May 1999 WO
WO 9930766 Jun 1999 WO
0 934 729 Aug 1999 WO
WO 9940964 Aug 1999 WO
WO 9942059 Aug 1999 WO
WO 9944510 Sep 1999 WO
WO 9944542 Sep 1999 WO
WO 9955236 Nov 1999 WO
WO 9958068 Nov 1999 WO
WO 0007521 Feb 2000 WO
WO 0007655 Feb 2000 WO
WO 0009054 Feb 2000 WO
WO 0016705 Aug 2000 WO
WO 0049970 Aug 2000 WO
WO 0053120 Sep 2000 WO
WO 0067664 Nov 2000 WO
WO 0067665 Nov 2000 WO
WO 0067666 Nov 2000 WO
WO 0067668 Nov 2000 WO
WO 0067669 Nov 2000 WO
WO 0105462 Jan 2001 WO
WO 0108595 Feb 2001 WO
WO 0108596 Feb 2001 WO
WO 0108742 Feb 2001 WO
WO 0108743 Feb 2001 WO
WO 0110320 Feb 2001 WO
WO 0115629 Mar 2001 WO
WO 0121077 Mar 2001 WO
WO 0121100 Mar 2001 WO
WO 0126726 Apr 2001 WO
WO 0135857 May 2001 WO
0145592 Jun 2001 WO
WO 01436623 Jun 2001 WO
WO 0147579 Jul 2001 WO
WO 0149208 Jul 2001 WO
WO 0149209 Jul 2001 WO
WO 0149215 Jul 2001 WO
WO 0149355 Jul 2001 WO
WO 0152768 Jul 2001 WO
WO 0158382 Aug 2001 WO
WO 0160442 Aug 2001 WO
WO 0167989 Sep 2001 WO
WO 0170326 Sep 2001 WO
WO 0172205 Oct 2001 WO
WO 0187183 Nov 2001 WO
WO 0189413 Nov 2001 WO
WO 0191824 Dec 2001 WO
2006200162 Aug 2006 WO
Related Publications (1)
Number Date Country
20060195138 A1 Aug 2006 US
Continuations (1)
Number Date Country
Parent 10140404 May 2002 US
Child 11381471 US